Literature DB >> 19216847

Surgical salvage of cancer of the oropharynx after chemoradiation.

Jeffrey M Bumpous1.   

Abstract

Advanced oropharyngeal squamous cell carcinoma is treated primarily with chemoradiation, with the goal of excellent disease control and preservation of swallowing and articulation functions of the oropharynx. Disease control rates generally are excellent; however, a significant number of patients do not achieve locoregional control of disease. The importance of human papillomavirus expression in predicting successful tumor response, locoregional control, and survival following chemoradiation is increasingly confirmed. Emerging is a clinical profile, viral expression, and genetic expression pattern that can predict success of chemoradiation and indicate which patients are at higher risk for locoregional failure necessitating surgical salvage. Successful surgical salvage depends on restaging at the time of recurrence and the time interval from chemoradiation to recurrence. Although surgical morbidity and mortality remain a challenge in patients undergoing salvage surgery of the oropharynx after radiation failure with or without chemotherapy, they may be mitigated by liberal application of regional and microvascular free flap reconstruction techniques.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19216847     DOI: 10.1007/s11912-009-0022-6

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  16 in total

1.  Changes in treatment of advanced oropharyngeal cancer, 1985-2001.

Authors:  Amy Y Chen; Nicole Schrag; Yongping Hao; Andrew Stewart; Elizabeth Ward
Journal:  Laryngoscope       Date:  2007-01       Impact factor: 3.325

2.  Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.

Authors:  Anthony J Cmelak; Sigui Li; Meredith A Goldwasser; Barbara Murphy; Michael Cannon; Harlan Pinto; David I Rosenthal; Maura Gillison; Arlene A Forastiere
Journal:  J Clin Oncol       Date:  2007-09-01       Impact factor: 44.544

3.  Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx.

Authors:  Sang Yoon Kim; Jong-Lyel Roh; Mi Ra Kim; Jae Seung Kim; Seung-Ho Choi; Soon Yuhl Nam; Sang-wook Lee; Sung-Bae Kim
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

4.  Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients.

Authors:  Marc A Cohen; Suzanne R Basha; Dawn K Reichenbach; Erle Robertson; Duane A Sewell
Journal:  Acta Otolaryngol       Date:  2008-05       Impact factor: 1.494

5.  Effect of body mass index on chemoradiation outcomes in head and neck cancer.

Authors:  Theodore R McRackan; John M Watkins; Amy E Herrin; Elizabeth M Garrett-Mayer; Anand K Sharma; Terry A Day; M Boyd Gillespie
Journal:  Laryngoscope       Date:  2008-07       Impact factor: 3.325

6.  Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.

Authors:  Francis P Worden; Bhavna Kumar; Julia S Lee; Gregory T Wolf; Kitrina G Cordell; Jeremy M G Taylor; Susan G Urba; Avraham Eisbruch; Theodoros N Teknos; Douglas B Chepeha; Mark E Prince; Christina I Tsien; Nisha J D'Silva; Kun Yang; David M Kurnit; Heidi L Mason; Tamara H Miller; Nancy E Wallace; Carol R Bradford; Thomas E Carey
Journal:  J Clin Oncol       Date:  2008-05-12       Impact factor: 44.544

7.  Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience.

Authors:  Kim Huang; Ping Xia; Cynthia Chuang; Vivian Weinberg; Christine M Glastonbury; David W Eisele; Nancy Y Lee; Sue S Yom; Theodore L Phillips; Jeanne M Quivey
Journal:  Cancer       Date:  2008-08-01       Impact factor: 6.860

8.  Tumor volume as a prognostic factor in oropharyngeal squamous cell carcinoma treated with primary radiotherapy.

Authors:  Mark J Been; Joanna Watkins; Ryan M Manz; Lindell R Gentry; Glen E Leverson; Paul M Harari; Gregory K Hartig
Journal:  Laryngoscope       Date:  2008-08       Impact factor: 3.325

9.  Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.

Authors:  Sophie Périé; Alexis Hugentobler; Bertrand Susini; Sona Balogova; Dany Grahek; Khaldoun Kerrou; Françoise Montravers; Pierre El Chater; Jean Lacau St Guily; Jean-Noël Talbot
Journal:  Otolaryngol Head Neck Surg       Date:  2007-10       Impact factor: 3.497

10.  Predictors of quality of life after treatment for oral cavity and oropharyngeal carcinoma.

Authors:  Theresa A Gurney; David W Eisele; Lisa A Orloff; Steven J Wang
Journal:  Otolaryngol Head Neck Surg       Date:  2008-08       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.